FDA Approved: * July 15, 2016
Pharm Company: * ANI PHARMS INC
Category: Cancer

Nilutamide, sold under the brand names Nilandron and Anandron, is a nonsteroidal antiandrogen (NSAA) which is used in the treatment of prostate cancer.[7][8][9][10][11][12] It has also been studied as a component of feminizing hormone therapy for transgender women and to treat acne and seborrhea in women.[13][14][15][16] It is taken by... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Nilutamide 150 mg Oral Tablet
NDC: 62559-173
Ani Pharmaceuticals, Inc.
Nilutamide 150 mg Oral Tablet
NDC: 66993-212
Prasco Laboratories

Related Brands

Drugs with the same active ingredients

Popular Topics

Nilutamide Hygroscopicity

plz let me know the Hygroscopicity of Nilutamide...